Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$2.27B |
| 2 |
Blackrock
BLK
|
+$1.21B |
| 3 |
PG&E
PCG
|
+$1.17B |
| 4 |
Alibaba
BABA
|
+$1.12B |
| 5 |
T-Mobile US
TMUS
|
+$826M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Treasury Bond ETF
GOVT
|
+$1.34B |
| 2 |
Boston Scientific
BSX
|
+$1.26B |
| 3 |
American Express
AXP
|
+$1.23B |
| 4 |
GE Aerospace
GE
|
+$1.1B |
| 5 |
Visa
V
|
+$993M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.88% |
| 2 | Healthcare | 16.37% |
| 3 | Consumer Discretionary | 13.18% |
| 4 | Financials | 11.24% |
| 5 | Communication Services | 10.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BPFH
1151
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $50.6M | 0.01% |
7,353,869
+464,482
| +7% | +$3.25M |
|
1152
BridgeBio Pharma
BBIO
$16.5B
| $50.5M | 0.01% |
1,548,896
-78,356
| -5% | -$2.39M |
|
1153
Harley-Davidson
HOG
$2.71B
| $50.3M | 0.01% |
2,115,557
+1,892,167
| +847% | +$41.1M |
|
|
BLUE
1154
DELISTED
bluebird bio
BLUE
| $50.3M | 0.01% |
63,561
-220,512
| -78% | -$166M |
|
1155
Steven Madden
SHOO
$3.55B
| $50.3M | 0.01% |
2,035,267
-1,182,977
| -37% | -$27.7M |
|
1156
Center Bancorp
CNOB
$1.78B
| $50M | 0.01% |
3,098,640
+739,351
| +31% | +$10.5M |
|
1157
Verra Mobility
VRRM
$744M
| $49.9M | 0.01% |
4,849,961
-6,687,829
| -58% | -$63.3M |
|
1158
Bank of N.T. Butterfield & Son
NTB
$2.45B
| $49.7M | 0.01% |
2,038,777
+1,133,552
| +125% | +$24.7M |
|
1159
Illumina
ILMN
$28.4B
| $49.7M | 0.01% |
137,962
+36,008
| +35% | +$11.6M |
|
1160
Cimpress
CMPR
$2.31B
| $49.6M | 0.01% |
650,200
+149,989
| +30% | +$10.7M |
|
1161
Cousins Properties
CUZ
$4.88B
| $49.5M | 0.01% |
1,658,347
+9,160
| +0.6% | +$275K |
|
|
PENG
1162
Penguin Solutions Inc
PENG
$2.99B
| $49.3M | 0.01% |
3,626,716
+222,686
| +7% | +$2.84M |
|
1163
KALA BIO
KALA
$14.5M
| $49.2M | 0.01% |
1,873
+731
| +64% | +$20.7M |
|
|
TMX
1164
DELISTED
Terminix Global Holdings, Inc.
TMX
| $49.1M | 0.01% |
1,375,573
-39,665
| -3% | -$1.22M |
|
1165
Brookfield Infrastructure
BIPC
$4.85B
| $49M | 0.01% |
1,614,375
+1,605,187
| +17,470% | +$46.6M |
|
|
NEWR
1166
DELISTED
New Relic, Inc.
NEWR
| $48.9M | 0.01% |
710,001
-68,102
| -9% | -$4.07M |
|
|
ALLK
1167
DELISTED
Allakos
ALLK
| $48.8M | 0.01% |
679,186
-345,094
| -34% | -$23.1M |
|
1168
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.66B
| $48.8M | 0.01% |
37,608
-22,969
| -38% | -$30.7M |
|
|
GMS
1169
DELISTED
GMS Inc
GMS
| $48.7M | 0.01% |
1,982,480
+1,387,487
| +233% | +$26.5M |
|
1170
Golar LNG
GLNG
$5.13B
| $48.6M | 0.01% |
6,716,470
-2,541,446
| -27% | -$17.6M |
|
|
MNRL
1171
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
| $48.6M | 0.01% |
3,937,454
+2,085,381
| +113% | +$25.3M |
|
|
WPX
1172
DELISTED
WPX Energy, Inc.
WPX
| $48.5M | 0.01% |
7,597,137
+2,872,074
| +61% | +$16.2M |
|
1173
Simpson Manufacturing
SSD
$8.16B
| $48.5M | 0.01% |
574,394
-68,032
| -11% | -$5.02M |
|
|
DCPH
1174
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $48.5M | 0.01% |
811,400
-148,753
| -15% | -$7.96M |
|
1175
Utah Medical Products
UTMD
$225M
| $48.4M | 0.01% |
546,364
+112,808
| +26% | +$10.1M |
|
Similar funds
Fidelity Investments's Q2 2020 Portfolio in Review
As of Q2 2020, Fidelity Investments held 4,490 positions worth $909B, up 26% from $722B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Fidelity Investments's Q2 2020 filing shows 334 new, 1,365 increased, 1,743 reduced and 502 closed positions. Its largest new stake was Royalty Pharma: 16,356,491 shares worth $743M. The largest sale was iShares US Treasury Bond ETF, an estimated $1.34B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Fidelity Investments's largest Q2 2020 buy was Royalty Pharma: 16,356,491 shares worth $743M.
- Fidelity Investments added most to Regeneron Pharmaceuticals in Q2 2020, an estimated $2.27B increase.
- Fidelity Investments's biggest Q2 2020 reduction was iShares US Treasury Bond ETF, cutting an estimated $1.34B.
- Fidelity Investments fully exited Sprint Corporation in Q2 2020, selling an estimated $225M.
- Fidelity Investments's ten largest holdings make up 28% of its $909B portfolio in Q2 2020.
- Fidelity Investments opened 334 new positions and closed 502 in Q2 2020.
- Fidelity Investments's portfolio value rose 26% quarter-over-quarter to $909B.
Based on Fidelity Investments's 13F filing for Q2 2020, filed 13 Aug 2020.